Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs Boston Medical Group

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Boston Medical Group head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 188 · Grade C

Boston Medical Group

Visit Boston Medical Group Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 68 on our six-factor Brief Score — One price on both molecules that does not climb as you titrate — but the headline $99 and $149 are annual-plan rates, paid in full up front.

That doesn't make Boston Medical Group a bad call — it's best for budget-conscious shoppers. Weigh the six factors below against your own priorities before you decide.

Why CoreAge Rx leads: it's our #1 here — one flat, no-step-up price on both molecules, nationwide, and the steadiest line on our tracker.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
48
Supply Reliability
95
74
Transparency
90
88
Access Breadth
93
46
Clinical Oversight
92
82
Track Record
88
77
CoreAge RxBrief Score 94 · 68Boston Medical Group

Price, coverage & the tracker

CoreAge RxBoston Medical Group
Brief Score94/100 (A)68/100 (C)
Semaglutide$99/mo only on a 12-month plan paid in full ($1,188 in one charge); month-to-month rate not publishedFrom $199/mo (starting strength, rising with dose, compounded)
Tirzepatide$149/mo only on a 12-month plan paid in full ($1,788 in one charge); month-to-month rate not publishedNot disclosed
CoverageUS only; restrictions by state, confirmed at intake7 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: Headline unchanged for a third straight cycle. The $99 and $149 are the 12-month prepay rates; CoreAge publishes no month-to-month price.

Boston Medical Group: New to the tracker on 1 August 2026, and read on the provider's own site rather than taken on trust: we checked https://www.bostonmedicalgroup.com/weight-loss/costs-dosing/ on 2026-08-01 and this row reflects what that page says. The line we publish is From $199/mo (starting strength, rising with dose, compounded). There is no earlier reading of ours to compare it against yet.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.